Whitehawk Therapeutics, INC. (WHWK) — 8-K Filings

8-K Filings (11)

• Whitehawk Therapeutics Files 8-K on Shareholder Vote — Jun 13, 2025 Risk: low
  Whitehawk Therapeutics, Inc. filed an 8-K on June 13, 2025, reporting on a matter submitted to a vote of security holders on June 11, 2025. The company, formerl
• Whitehawk Therapeutics Completes Asset Acquisition/Disposition — Mar 26, 2025 Risk: medium
  On March 25, 2025, Whitehawk Therapeutics, Inc. (formerly Aadi Bioscience, Inc. and Aerpio Pharmaceuticals, Inc.) filed an 8-K report detailing the completion o
• Whitehawk Therapeutics, Inc. (fka Aadi Bioscience) Files 8-K — Mar 18, 2025 Risk: medium
  On March 18, 2025, Whitehawk Therapeutics, Inc. (formerly Aadi Bioscience, Inc.) filed an 8-K report. The filing indicates a change in the company's name and po
• Aadi Bioscience Files 8-K: Material Agreement & Shareholder Vote — Mar 4, 2025 Risk: medium
  On February 28, 2025, Aadi Bioscience, Inc. entered into a Material Definitive Agreement. The company also submitted matters to a vote of its security holders a
• Aadi Bioscience Files 8-K: Agreements, Equity Sales, Officer Changes — Dec 20, 2024 Risk: medium
  On December 19, 2024, Aadi Bioscience, Inc. entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing. The compa
• Aadi Bioscience Appoints New Chief Medical Officer — Sep 30, 2024 Risk: medium
  On September 26, 2024, Aadi Bioscience, Inc. announced the appointment of Dr. Michael J. Nally as its new Chief Medical Officer. Dr. Nally brings extensive expe
• Aadi Bioscience Appoints New CMO, Elects Director — Sep 19, 2024 Risk: medium
  Aadi Bioscience, Inc. announced on September 15, 2024, the appointment of Dr. Rajul Patel as Chief Medical Officer and the election of Ms. Sarah Kelly to its Bo
• Aadi Bioscience Appoints New CMO, Director — Aug 22, 2024 Risk: medium
  Aadi Bioscience, Inc. announced on August 16, 2024, the appointment of Dr. Rajul Patel as Chief Medical Officer and the election of Ms. Sarah E. Kelly to its Bo
• Aadi Bioscience to be Acquired for $100M — Aug 21, 2024 Risk: medium
  Aadi Bioscience, Inc. reported on August 16, 2024, that it has entered into a definitive agreement to be acquired by Anria Acquisition Corp., a wholly-owned sub
• Aadi Bioscience Files 8-K on Shareholder Vote Matters — Jun 12, 2024 Risk: medium
  On June 11, 2024, Aadi Bioscience, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing indicates that the
• Aadi Bioscience Enters Material Definitive Agreement — Apr 4, 2024 Risk: medium
  On April 1, 2024, Aadi Bioscience, Inc. entered into a Material Definitive Agreement. The company, formerly known as Aerpio Pharmaceuticals, Inc. and Zeta Acqui

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX